Literature DB >> 25824528

The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system.

João P Lopes1, Xavier Morató2, Carolina Souza1, Cindy Pinhal1, Nuno J Machado1, Paula M Canas1, Henrique B Silva1, Igor Stagljar3, Jorge Gandía2, Víctor Fernández-Dueñas2, Rafael Luján4, Rodrigo A Cunha1,5, Francisco Ciruela2,6.   

Abstract

GPR37 is an orphan G protein-coupled receptor mostly enriched in brain areas such as the cerebellum, striatum, and hippocampus. Identified as a substrate of parkin, GPR37 has been suggested to play a role in Parkinson's disease. Distributed throughout the brain, the function of GPR37, however, remains unknown. We now provide the first mapping of GPR37 within the hippocampus, where GPR37 is widely expressed and localized at the level of the extrasynaptic plasma membrane of dendritic spines, dendritic shafts, and axon terminals. GPR37 per se does not appear to play a role in learning and memory, since knocking out GPR37 (GPR37-KO) did not alter the performance in different hippocampal-related memory tasks. This is in agreement with slice electrophysiology experiments showing no differences both in short-term plasticity paired-pulse facilitation and long-term potentiation between WT and GPR37-KO mice. However, we report a potential functional interaction between GPR37 and adenosine A2A receptors (A2 A R) in the hippocampus, with A2 A R modulating the GPR37-associated phenotype. Thus, the absence of GPR37 appeared to sensitize mice to hippocampal A2 A R-mediated signaling, as observed by the effect of the A2 A R antagonist SCH58261 increasing synaptic depotentiation, reducing novel object recognition memory and reverting the anxiolytic effect of GPR37 deletion. Collectively, these findings afford insight into the localization and role of the orphan GPR37 within the hippocampus with potential involvement in A2 A R function (i.e., A2 A R sensitization). GPR37 is an orphan G protein-coupled receptor widely expressed in the hippocampus and localized at the level of the extrasynaptic plasma membrane of dendritic spines, dendritic shafts and axon terminals. This orphan receptor per se does not appear to directly control the learning and memory processes; however knocking-out GPR37 triggers anxiolytic-like effects and sensitizes mice to hippocampal A2A R-mediated signalling.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  GPR37; adenosine A2A receptor; hippocampus; synaptic plasticity

Mesh:

Substances:

Year:  2015        PMID: 25824528     DOI: 10.1111/jnc.13109

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

1.  Parkinson's disease-associated receptor GPR37 is an ER chaperone for LRP6.

Authors:  Birgit S Berger; Sergio P Acebron; Jessica Herbst; Stefan Koch; Christof Niehrs
Journal:  EMBO Rep       Date:  2017-03-24       Impact factor: 8.807

2.  Brain Membrane Fractionation: An Ex Vivo Approach to Assess Subsynaptic Protein Localization.

Authors:  Xavier Morató; Marc López-Cano; Paula M Canas; Rodrigo A Cunha; Francisco Ciruela
Journal:  J Vis Exp       Date:  2017-05-12       Impact factor: 1.355

Review 3.  New Advances in Targeting the Resolution of Inflammation: Implications for Specialized Pro-Resolving Mediator GPCR Drug Discovery.

Authors:  Julia Park; Christopher J Langmead; Darren M Riddy
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-20

4.  Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice.

Authors:  Myles R McCrary; Michael Q Jiang; Michelle M Giddens; James Y Zhang; Sharon Owino; Zheng Z Wei; Weiwei Zhong; Xiaohuan Gu; Huang Xin; Randy A Hall; Ling Wei; Shan P Yu
Journal:  FASEB J       Date:  2019-07-03       Impact factor: 5.834

5.  The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo.

Authors:  Xavier Morató; Rafael Luján; Marc López-Cano; Jorge Gandía; Igor Stagljar; Masahiko Watanabe; Rodrigo A Cunha; Víctor Fernández-Dueñas; Francisco Ciruela
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

6.  Systematic protein-protein interaction mapping for clinically relevant human GPCRs.

Authors:  Kate Sokolina; Saranya Kittanakom; Jamie Snider; Max Kotlyar; Pascal Maurice; Jorge Gandía; Abla Benleulmi-Chaachoua; Kenjiro Tadagaki; Atsuro Oishi; Victoria Wong; Ramy H Malty; Viktor Deineko; Hiroyuki Aoki; Shahreen Amin; Zhong Yao; Xavier Morató; David Otasek; Hiroyuki Kobayashi; Javier Menendez; Daniel Auerbach; Stephane Angers; Natasa Pržulj; Michel Bouvier; Mohan Babu; Francisco Ciruela; Ralf Jockers; Igor Jurisica; Igor Stagljar
Journal:  Mol Syst Biol       Date:  2017-03-15       Impact factor: 11.429

Review 7.  Orphan G Protein Coupled Receptors in Affective Disorders.

Authors:  Lyndsay R Watkins; Cesare Orlandi
Journal:  Genes (Basel)       Date:  2020-06-24       Impact factor: 4.096

8.  G protein-coupled receptor 37 (GPR37) emerges as an important modulator of adenosinergic transmission in the striatum.

Authors:  Xavier Morato; Rodrigo A Cunha; Francisco Ciruela
Journal:  Neural Regen Res       Date:  2019-11       Impact factor: 5.135

Review 9.  Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1.

Authors:  Nicola J Smith
Journal:  Front Pharmacol       Date:  2015-11-17       Impact factor: 5.810

10.  Spatiotemporal Control of GPR37 Signaling and Its Behavioral Effects by Optogenetics.

Authors:  Wu Zheng; Jianhong Zhou; Yanan Luan; Jianglan Yang; Yuanyuan Ge; Muran Wang; Beibei Wu; Zhongnan Wu; Xingjun Chen; Fei Li; Zhihui Li; Sergii Vakal; Wei Guo; Jiang-Fan Chen
Journal:  Front Mol Neurosci       Date:  2018-03-28       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.